Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species

Detaylı Bibliyografya
Asıl Yazarlar:	Dicks, M, Spencer, A, Edwards, N, Gilbert, S, Hill, S, Cottingham, MG
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	2011

Benzer Materyaller

Uncovering the mechanisms of adenovirus vector immunogenicity
Yazar:: Dicks, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
Yazar:: Dicks, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
Yazar:: Matthew D J Dicks, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
Yazar:: Eriko Padron-Regalado, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
Yazar:: Warimwe, G, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
Yazar:: Dicks, M, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Yazar:: Ewer (nee Russell), K, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Novel adenovirus vaccine vectors
Yazar:: Dicks, M
Baskı/Yayın Bilgisi: (2013)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
Yazar:: Dicks, M, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Yazar:: Katie Ewer, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

Simian adenoviruses as vaccine vectors
Yazar:: Morris, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Simian adenoviruses as vaccine vectors
Yazar:: Morris, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
Yazar:: Alcock, R, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Adenoviral vectors as novel vaccines for influenza.
Yazar:: Coughlan, L, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
Yazar:: Iampietro, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Yazar:: Lynda Coughlan
Baskı/Yayın Bilgisi: (2020-05-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
Yazar:: Marta Ulaszewska, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

MAIT cell activation augments adenovirus vector vaccine immunogenicity
Yazar:: Provine, N, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
Yazar:: Goodman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
Yazar:: Jingao Guo, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Yazar:: Reyes-Sandoval, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Adenovirus vector and mRNA vaccines: mechanisms regulating their immunogenicity
Yazar:: Provine, NM, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
Yazar:: Cottingham, MG, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
Yazar:: Cottingham, MG, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
Yazar:: Reyes-Sandoval, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
Yazar:: Reyes-Sandoval, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
Yazar:: Reyes-Sandoval, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
Yazar:: Biswas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
Yazar:: Draper, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
Yazar:: Folegatti, P, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Using multivalent adenoviral vectors for HIV vaccination.
Yazar:: Linlin Gu, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

An Adenoviral Vector Based Vaccine for Rhodococcus equi.
Yazar:: Carla Giles, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Yazar:: Folegatti, P, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
Yazar:: Reyes-Sandoval, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
Yazar:: Pedro M. Folegatti, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Yazar:: Pedro M. Folegatti, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.
Yazar:: Bruna de Andrade Pereira, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Pandemic-response adenoviral vector and RNA vaccine manufacturing
Yazar:: Zoltán Kis, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

The use of adenoviral vectors in gene therapy and vaccine approaches
Yazar:: Natália Meneses Araújo, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
Yazar:: Ekramy E. Sayedahmed, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)